Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Limited proprietary earnings coverage for AMRX yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 33d ago
Reported figures for Amneal Pharmaceuticals, Inc. — research only, not investment advice.
Updated
What happened recently for Amneal Pharmaceuticals, Inc. (AMRX) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$17.27
Market cap
$5.52B
Profitable
Yes
Revenue $722.52M
Net income
$62.26M
FY Jul 21, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Amneal Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Amneal Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.